Nova Leap Health Corp.
NLH.V
TSX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 390.52% | 230.70% | 56.79% | 113.95% | 61.68% |
| Total Depreciation and Amortization | -21.35% | -34.04% | -37.68% | -40.15% | -36.35% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -127.36% | -136.71% | -11.82% | -56.61% | 119.96% |
| Change in Net Operating Assets | 1,241.72% | 141.48% | 3,840.54% | 88.82% | 104.75% |
| Cash from Operations | -45.83% | -35.58% | 14.08% | -14.65% | 136.04% |
| Capital Expenditure | -- | 10.71% | 100.00% | 100.00% | 100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -100.00% | -100.00% | -100.00% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -6,787.45% | -686.16% | -502.41% | 100.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 69.22% | 76.97% | 52.83% | 58.46% | 37.10% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -51.10% | 80.26% | 95.06% | 91.50% | 88.31% |
| Cash from Financing | 178.16% | 129.01% | 55.72% | 20.40% | -24.53% |
| Foreign Exchange rate Adjustments | -1,092.86% | -380.60% | -84.25% | 95.24% | 105.67% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2.74% | 234.43% | 123.09% | -36.92% | 129.55% |